Rima McLeod - Publications

Affiliations: 
Stanford University School of Medicine, Palo Alto, CA, United States 

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Felín MS, Wang K, Raggi C, Moreira A, Pandey A, Grose A, Caballero Z, Rengifo-Herrera C, Ramirez M, Moossazadeh D, Castro C, Montalvo JLS, Leahy K, Zhou Y, Clouser FA, ... ... McLeod R, et al. Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors. Current Pediatrics Reports. 10: 109-124. PMID 37744780 DOI: 10.1007/s40124-022-00265-0  0.46
2022 Felín MS, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Caballero Z, ... ... McLeod R, et al. Building Programs to Eradicate Toxoplasmosis Part II: Education. Current Pediatrics Reports. 10: 93-108. PMID 36969368 DOI: 10.1007/s40124-022-00267-y  0.503
2022 Felín MS, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Caballero Z, ... ... McLeod R, et al. Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview. Current Pediatrics Reports. 10: 57-92. PMID 36034212 DOI: 10.1007/s40124-022-00269-w  0.491
2022 Felín MS, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, Clouser FA, Siddiqui M, Leong N, Goodall P, Michalowski M, Ismail M, Christmas M, Schrantz S, Caballero Z, ... ... McLeod R, et al. Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village". Current Pediatrics Reports. 1-30. PMID 35991908 DOI: 10.1007/s40124-022-00268-x  0.46
2021 Montoya JG, Laessig K, Fazeli MS, Siliman G, Yoon SS, Drake-Shanahan E, Zhu C, Akbary A, McLeod R. A fresh look at the role of spiramycin in preventing a neglected disease: meta-analyses of observational studies. European Journal of Medical Research. 26: 143. PMID 34895348 DOI: 10.1186/s40001-021-00606-7  0.513
2021 Del Valle Mojica C, Montoya JG, McGuire J, Palma KL, Shekdar KV, McLeod R, Contopoulos-Ioannidis DG. Late Diagnosis of Congenital Toxoplasmosis With Macrocephaly in Dizygotic Twins After Incidental Detection of Leukocoria: A Case Report. The Journal of Pediatrics. PMID 34023345 DOI: 10.1016/j.jpeds.2021.05.040  0.538
2020 McPhillie MJ, Zhou Y, Hickman MR, Gordon JA, Weber CR, Li Q, Lee PJ, Amporndanai K, Johnson RM, Darby H, Woods S, Li ZH, Priestley RS, Ristroph KD, Biering SB, ... ... McLeod R, et al. Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites. Frontiers in Cellular and Infection Microbiology. 10: 203. PMID 32626661 DOI: 10.3389/Fcimb.2020.00203  0.323
2018 Gomez CA, Budvytyte LN, Press C, Zhou L, McLeod R, Maldonado Y, Montoya JG, Contopoulos-Ioannidis DG. Evaluation of Three Point-of-Care Tests for Detection of Immunoglobulin IgG and IgM in the United States: Proof of Concept and Challenges. Open Forum Infectious Diseases. 5: ofy215. PMID 30393749 DOI: 10.1093/Ofid/Ofy215  0.527
2018 El Bissati K, Levigne P, Lykins J, Adlaoui EB, Barkat A, Berraho A, Laboudi M, El Mansouri B, Ibrahimi A, Rhajaoui M, Quinn F, Murugesan M, Seghrouchni F, Gómez-Marín JE, Peyron F, ... McLeod R, et al. Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerging Microbes & Infections. 7: 165. PMID 30262847 DOI: 10.1038/S41426-018-0164-4  0.324
2018 Lykins J, Li X, Levigne P, Zhou Y, El Bissati K, Clouser F, Wallon M, Morel F, Leahy K, El Mansouri B, Siddiqui M, Leong N, Michalowski M, Irwin E, Goodall P, ... ... McLeod R, et al. Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies. Plos Neglected Tropical Diseases. 12: e0006536. PMID 30114251 DOI: 10.1371/Journal.Pntd.0006536  0.522
2017 Ngô HM, Zhou Y, Lorenzi H, Wang K, Kim TK, Zhou Y, Bissati KE, Mui E, Fraczek L, Rajagopala SV, Roberts CW, Henriquez FL, Montpetit A, Blackwell JM, Jamieson SE, ... ... McLeod R, et al. Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. Scientific Reports. 7: 11496. PMID 28904337 DOI: 10.1038/S41598-017-10675-6  0.327
2017 Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El Bissati K, Boyer K, Withers S, Clouser F, Noble AG, Rabiah P, Swisher CN, Heydemann PT, Contopoulos-Ioannidis DG, Montoya JG, ... ... McLeod R, et al. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. Plos Neglected Tropical Diseases. 11: e0005670. PMID 28650970 DOI: 10.1371/Journal.Pntd.0005670  0.581
2017 Ying Y, Verma SK, Kwok OC, Alibana F, Mcleod R, Su C, Dubey JP, Pradhan AK. Prevalence and genetic characterization of Toxoplasma gondii in free-range chickens from grocery stores and farms in Maryland, Ohio and Massachusetts, USA. Parasitology Research. PMID 28337538 DOI: 10.1007/S00436-017-5420-3  0.3
2016 McPhillie M, Zhou Y, El Bissati K, Dubey J, Lorenzi H, Capper M, Lukens AK, Hickman M, Muench S, Verma SK, Weber CR, Wheeler K, Gordon J, Sanders J, Moulton H, ... ... McLeod R, et al. New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Scientific Reports. 6: 29179. PMID 27412848 DOI: 10.1038/Srep29179  0.353
2016 Lykins J, Wang K, Wheeler K, Clouser F, Dixon A, El Bissati K, Zhou Y, Lyttle C, Rzhetsky A, McLeod R. Understanding Toxoplasmosis in the United States Through "Large Data" Analyses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27353665 DOI: 10.1093/Cid/Ciw356  0.312
2015 Contopoulos-Ioannidis D, Wheeler KM, Ramirez R, Press C, Mui E, Zhou Y, Van Tubbergen C, Prasad S, Maldonado Y, Withers S, Boyer KM, Noble AG, Rabiah P, Swisher CN, Heydemann P, ... ... McLeod R, et al. Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26405150 DOI: 10.1093/Cid/Civ721  0.586
2015 Hutson SL, Wheeler KM, McLone D, Frim D, Penn R, Swisher CN, Heydemann PT, Boyer KM, Noble AG, Rabiah P, Withers S, Montoya JG, Wroblewski K, Karrison T, Grigg ME, ... McLeod R, et al. Patterns of Hydrocephalus Caused by Congenital Toxoplasma gondii Infection Associate With Parasite Genetics. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26405147 DOI: 10.1093/Cid/Civ720  0.582
2015 Sanders JL, Zhou Y, Moulton HM, Moulton ZX, McLeod R, Dubey JP, Weiss LM, Kent ML. The zebrafish, Danio rerio, as a model for Toxoplasma gondii: an initial description of infection in fish. Journal of Fish Diseases. 38: 675-9. PMID 25951508 DOI: 10.1111/Jfd.12393  0.376
2015 Edelblum KL, Singh G, Odenwald MA, Lingaraju A, El Bissati K, McLeod R, Sperling AI, Turner JR. γδ Intraepithelial Lymphocyte Migration Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice. Gastroenterology. 148: 1417-26. PMID 25747597 DOI: 10.1053/J.Gastro.2015.02.053  0.305
2014 Witola WH, Liu SR, Montpetit A, Welti R, Hypolite M, Roth M, Zhou Y, Mui E, Cesbron-Delauw MF, Fournie GJ, Cavailles P, Bisanz C, Boyer K, Withers S, Noble AG, ... ... McLeod R, et al. ALOX12 in human toxoplasmosis. Infection and Immunity. 82: 2670-9. PMID 24686056 DOI: 10.1128/Iai.01505-13  0.335
2014 McLeod R, Lykins J, Noble AG, Rabiah P, Swisher CN, Heydemann PT, McLone D, Frim D, Withers S, Clouser F, Boyer K. Management of Congenital Toxoplasmosis Current Pediatrics Reports. 2: 166-194. DOI: 10.1007/S40124-014-0055-7  0.337
2012 Béla SR, Dutra MS, Mui E, Montpetit A, Oliveira FS, Oliveira SC, Arantes RM, Antonelli LR, McLeod R, Gazzinelli RT. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii. Infection and Immunity. 80: 4298-308. PMID 23027530 DOI: 10.1128/Iai.00328-12  0.345
2012 Fomovska A, Wood RD, Mui E, Dubey JP, Ferreira LR, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Welsh WJ, Sommerville C, Woods S, Roberts C, McLeod R. Salicylanilide inhibitors of Toxoplasma gondii. Journal of Medicinal Chemistry. 55: 8375-91. PMID 22970937 DOI: 10.1021/Jm3007596  0.355
2012 Lai BS, Witola WH, El Bissati K, Zhou Y, Mui E, Fomovska A, McLeod R. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proceedings of the National Academy of Sciences of the United States of America. 109: 14182-7. PMID 22891343 DOI: 10.1073/Pnas.1208775109  0.365
2012 McLeod R, Boyer KM, Lee D, Mui E, Wroblewski K, Karrison T, Noble AG, Withers S, Swisher CN, Heydemann PT, Sautter M, Babiarz J, Rabiah P, Meier P, Grigg ME, et al. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1595-605. PMID 22499837 DOI: 10.1093/Cid/Cis258  0.401
2012 Fomovska A, Huang Q, El Bissati K, Mui EJ, Witola WH, Cheng G, Zhou Y, Sommerville C, Roberts CW, Bettis S, Prigge ST, Afanador GA, Hickman MR, Lee PJ, Leed SE, ... ... McLeod R, et al. Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway. Antimicrobial Agents and Chemotherapy. 56: 2666-82. PMID 22354304 DOI: 10.1128/Aac.06450-11  0.301
2012 Dubey JP, Ferreira LR, Martins J, McLeod R. Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology. 139: 1-13. PMID 22078010 DOI: 10.1017/S0031182011001673  0.337
2011 Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, Sautter M, Noble AG, Withers S, Swisher C, Heydemann P, Hosten T, Babiarz J, Lee D, Meier P, ... McLeod R, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 1081-9. PMID 22021924 DOI: 10.1093/Cid/Cir667  0.386
2011 Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. The Pediatric Infectious Disease Journal. 30: 1056-61. PMID 21956696 DOI: 10.1097/Inf.0B013E3182343096  0.646
2011 Hill D, Coss C, Dubey JP, Wroblewski K, Sautter M, Hosten T, Muñoz-Zanzi C, Mui E, Withers S, Boyer K, Hermes G, Coyne J, Jagdis F, Burnett A, McLeod P, ... ... McLeod R, et al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. The Journal of Parasitology. 97: 328-37. PMID 21506817 DOI: 10.1645/Ge-2782.1  0.384
2011 Delair E, Latkany P, Noble AG, Rabiah P, McLeod R, Brézin A. Clinical manifestations of ocular toxoplasmosis. Ocular Immunology and Inflammation. 19: 91-102. PMID 21428746 DOI: 10.3109/09273948.2011.564068  0.33
2011 Kortagere S, Mui E, McLeod R, Welsh WJ. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach. Journal of Computer-Aided Molecular Design. 25: 403-11. PMID 21359560 DOI: 10.1007/S10822-011-9420-6  0.332
2011 Witola WH, Mui E, Hargrave A, Liu S, Hypolite M, Montpetit A, Cavailles P, Bisanz C, Cesbron-Delauw MF, Fournié GJ, McLeod R. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infection and Immunity. 79: 756-66. PMID 21098108 DOI: 10.1128/Iai.00898-10  0.358
2011 Remington JS, McLeod R, Wilson CB, Desmonts G. Toxoplasmosis Infectious Diseases of the Fetus and Newborn Infant. 918-1041. DOI: 10.1016/B978-1-4160-6400-8.00031-6  0.442
2010 Hutson SL, Mui E, Kinsley K, Witola WH, Behnke MS, El Bissati K, Muench SP, Rohrman B, Liu SR, Wollmann R, Ogata Y, Sarkeshik A, Yates JR, McLeod R. T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest. Plos One. 5: e14057. PMID 21124925 DOI: 10.1371/Journal.Pone.0014057  0.312
2010 Tan TG, Mui E, Cong H, Witola WH, Montpetit A, Muench SP, Sidney J, Alexander J, Sette A, Grigg ME, Maewal A, McLeod R. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine. 28: 3977-89. PMID 20347630 DOI: 10.1016/J.Vaccine.2010.03.028  0.318
2009 McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Memorias Do Instituto Oswaldo Cruz. 104: 320-44. PMID 19430661 DOI: 10.1590/S0074-02762009000200029  0.394
2009 Jamieson SE, Cordell H, Petersen E, McLeod R, Gilbert RE, Blackwell JM. Host genetic and epigenetic factors in toxoplasmosis. MemóRias Do Instituto Oswaldo Cruz. 104: 162-9. PMID 19430638 DOI: 10.1590/S0074-02762009000200006  0.33
2008 Hermes G, Ajioka JW, Kelly KA, Mui E, Roberts F, Kasza K, Mayr T, Kirisits MJ, Wollmann R, Ferguson DJ, Roberts CW, Hwang JH, Trendler T, Kennan RP, Suzuki Y, ... ... McLeod R, et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. Journal of Neuroinflammation. 5: 48. PMID 18947414 DOI: 10.1186/1742-2094-5-48  0.341
2008 Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Sautter M, ... ... McLeod R, et al. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. American Journal of Ophthalmology. 146: 375-384. PMID 18619570 DOI: 10.1016/J.Ajo.2008.04.033  0.476
2008 Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ, Kirisits MJ, Miller EN, Peacock CS, Hargrave AC, Coyne JJ, Boyer K, Bessieres MH, Buffolano W, Ferret N, ... ... McLeod R, et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. Plos One. 3: e2285. PMID 18523590 DOI: 10.1371/Journal.Pone.0002285  0.368
2008 Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Remington J, ... ... McLeod R, et al. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 115: 553-559.e8. PMID 17825418 DOI: 10.1016/J.Ophtha.2007.06.022  0.462
2006 Roizen N, Kasza K, Karrison T, Mets M, Noble AG, Boyer K, Swisher C, Meier P, Remington J, Jalbrzikowski J, McLeod R, Kipp M, Rabiah P, Chamot D, Estes R, et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics. 118: e379-90. PMID 16864640 DOI: 10.1542/Peds.2005-1530  0.456
2006 Muench SP, Prigge ST, Zhu L, Kirisits MJ, Roberts CW, Wernimont S, McLeod R, Rice DW. Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 62: 604-6. PMID 16754994 DOI: 10.1107/S1744309106018112  0.318
2006 McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, Jalbrzikowski J, Remington J, Heydemann P, Noble AG, Mets M, Holfels E, Withers S, Latkany P, Meier P, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 1383-94. PMID 16619149 DOI: 10.1086/501360  0.503
2005 Mui EJ, Jacobus D, Milhous WK, Schiehser G, Hsu H, Roberts CW, Kirisits MJ, McLeod R. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 49: 3463-7. PMID 16048961 DOI: 10.1128/Aac.49.8.3463-3467.2005  0.328
2005 Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J, Withers S, Meier P, McLeod R. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. American Journal of Obstetrics and Gynecology. 192: 564-71. PMID 15696004 DOI: 10.1016/J.Ajog.2004.07.031  0.502
2005 Henriquez FL, Richards TA, Roberts F, McLeod R, Roberts CW. The unusual mitochondrial compartment of Cryptosporidium parvum. Trends in Parasitology. 21: 68-74. PMID 15664529 DOI: 10.1016/J.Pt.2004.11.010  0.302
2003 Samuel BU, Hearn B, Mack D, Wender P, Rothbard J, Kirisits MJ, Mui E, Wernimont S, Roberts CW, Muench SP, Rice DW, Prigge ST, Law AB, McLeod R. Delivery of antimicrobials into parasites. Proceedings of the National Academy of Sciences of the United States of America. 100: 14281-6. PMID 14623959 DOI: 10.1073/Pnas.2436169100  0.324
2002 Johnson JJ, Roberts CW, Pope C, Roberts F, Kirisits MJ, Estes R, Mui E, Krieger T, Brown CR, Forman J, McLeod R. In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. Journal of Immunology (Baltimore, Md. : 1950). 169: 966-73. PMID 12097403 DOI: 10.4049/Jimmunol.169.2.966  0.32
2002 Lyons RE, McLeod R, Roberts CW. Toxoplasma gondii tachyzoite-bradyzoite interconversion. Trends in Parasitology. 18: 198-201. PMID 11983592 DOI: 10.1016/S1471-4922(02)02248-1  0.306
2002 Johnson J, Suzuki Y, Mack D, Mui E, Estes R, David C, Skamene E, Forman J, McLeod R. Genetic analysis of influences on survival following Toxoplasma gondii infection. International Journal For Parasitology. 32: 179-85. PMID 11812495 DOI: 10.1016/S0020-7519(01)00321-6  0.308
2000 Kirisits MJ, Mui E, McLeod R. Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. International Journal For Parasitology. 30: 149-55. PMID 10704598 DOI: 10.1016/S0020-7519(00)00009-6  0.353
2000 Roberts F, Roberts CW, Ferguson DJP, McLeod R. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis Parasite Immunology. 22: 1-5. PMID 10607284 DOI: 10.1046/J.1365-3024.2000.00259.X  0.306
1999 Mack DG, Johnson JJ, Roberts F, Roberts CW, Estes RG, David C, Grumet FC, McLeod R. HLA-class II genes modify outcome of Toxoplasma gondii infection. International Journal For Parasitology. 29: 1351-8. PMID 10579423 DOI: 10.1016/S0020-7519(99)00152-6  0.38
1998 Estes R, Vogel N, Mack D, McLeod R. Paclitaxel arrests growth of intracellular Toxoplasma gondii. Antimicrobial Agents and Chemotherapy. 42: 2036-40. PMID 9687403 DOI: 10.1128/Aac.42.8.2036  0.359
1998 Roberts F, Roberts CW, Johnson JJ, Kyle DE, Krell T, Coggins JR, Coombs GH, Milhous WK, Tzipori S, Ferguson DJ, Chakrabarti D, McLeod R. Evidence for the shikimate pathway in apicomplexan parasites. Nature. 393: 801-5. PMID 9655396 DOI: 10.1038/31723  0.328
1997 Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R. Eye manifestations of congenital toxoplasmosis. American Journal of Ophthalmology. 123: 1-16. PMID 9186091  0.462
1996 Vogel N, Kirisits M, Michael E, Bach H, Hostetter M, Boyer K, Simpson R, Holfels E, Hopkins J, Mack D, Mets MB, Swisher CN, Patel D, Roizen N, Stein L, ... ... McLeod R, et al. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 23: 1055-60. PMID 8922802 DOI: 10.1093/Clinids/23.5.1055  0.54
1996 Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R. Eye manifestations of congenital toxoplasmosis. American Journal of Ophthalmology. 122: 309-24. PMID 8794703 DOI: 10.1016/S0002-9394(14)72057-4  0.52
1996 Patel DV, Holfels EM, Vogel NP, Boyer KM, Mets MB, Swisher CN, Roizen NJ, Stein LK, Stein MA, Hopkins J, Withers SE, Mack DG, Luciano RA, Meier P, Remington JS, ... McLeod RL, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology. 199: 433-40. PMID 8668790 DOI: 10.1148/Radiology.199.2.8668790  0.414
1994 McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, Remington J, Meier P, Johnson D, Heydeman P, Holfels E, ... ... McLeod R, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial Clinical Infectious Diseases. 18: 38-72. PMID 8054436 DOI: 10.1093/Clinids/18.1.38  0.496
1993 Wong SY, Hajdu M-, Ramirez R, Thulliez P, Mcleod R, Remington JS. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. Journal of Clinical Microbiology. 31: 2952-2959. PMID 8263181 DOI: 10.1128/Jcm.31.11.2952-2959.1993  0.468
1985 McLeod R, Estes RG, Mack DG. Effects of adjuvants and Toxoplasma gondii antigens on immune response and outcome of peroral T. gondii challenge. Transactions of the Royal Society of Tropical Medicine and Hygiene. 79: 800-4. PMID 3832492 DOI: 10.1016/0035-9203(85)90122-1  0.328
1985 McLeod R, Estes RG, Cohen H. Influence of Toxoplasma on manifestations of Moloney virus infections. Transactions of the Royal Society of Tropical Medicine and Hygiene. 79: 781-7. PMID 2938310 DOI: 10.1016/0035-9203(85)90116-6  0.345
1984 McLeod R, Estes RG, Mack DG, Cohen H. Immune response of mice to ingested Toxoplasma gondii: a model of toxoplasma infection acquired by ingestion. The Journal of Infectious Diseases. 149: 234-44. PMID 6699433 DOI: 10.1093/Infdis/149.2.234  0.349
1982 McLeod R, Van Le L, Remington JS. Toxoplasma gondii: lymphocyte function during acute infection in mice. Experimental Parasitology. 54: 55-63. PMID 6980139 DOI: 10.1016/0014-4894(82)90110-2  0.444
1980 McLeod R, Bensch KG, Smith SM, Remington JS. Effects of human peripheral blood monocytes, monocyte-derived macrophages, and spleen mononuclear phagocytes on Toxoplasma gondii Cellular Immunology. 54: 330-350. PMID 7418010 DOI: 10.1016/0008-8749(80)90214-2  0.414
1980 McLeod R, Hirabayashi RN, Rothman W, Remington JS. Necrotizing vasculitis and Sarcocystis: a cause-and-effect relationship? Southern Medical Journal. 73: 1380-3. PMID 6776634 DOI: 10.1097/00007611-198010000-00026  0.443
1979 McLeod R, Berry PF, Marshall WH, Hunt SA, Ryning FW, Remington JS. Toxoplasmosis presenting as brain abscesses. Diagnosis by computerized tomography and cytology of aspirated purulent material The American Journal of Medicine. 67: 711-714. PMID 495641 DOI: 10.1016/0002-9343(79)90271-7  0.39
1979 McLeod R, Remington JS. A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen Journal of Immunological Methods. 27: 19-29. PMID 379229 DOI: 10.1016/0022-1759(79)90235-7  0.429
1979 Ryning FW, McLEOD R, Maddox JC, Hunt S, Remington JS. Probable Transmission of Toxoplasma gondii by Organ Transplantation Annals of Internal Medicine. 90: 47-49. PMID 369424 DOI: 10.7326/0003-4819-90-1-47  0.444
1977 McLeod R, Remington JS. Influence of infection with Toxoplasma on macrophage function, and role of macrophages in resistance to Toxoplasma. American Journal of Tropical Medicine and Hygiene. 26: 170-186. PMID 339761 DOI: 10.4269/Ajtmh.1977.26.170  0.52
1977 McLeod R, Remington JS. Studies on the specificity of killing of intracellular pathogens by macrophages Cellular Immunology. 34: 156-174. PMID 71951 DOI: 10.1016/0008-8749(77)90238-6  0.451
Show low-probability matches.